Magtrace Nanoparticles for Sentimag System is FDA Approved for Breast Lymph Node Biopsy
The Food and Drug Administration approved Endomagnetics Inc.’s magnetic tracer injection and detection system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. In the procedure, the clinician injects a soluti...
Source: Medgadget - Category: Medical Devices Authors: Ben Ouyang Tags: Oncology Surgery Source Type: blogs
More News: Allergy & Immunology | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Food and Drug Administration (FDA) | Iron | Mastectomy | Medical Devices | Nanotechnology